ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,565,095 | +529.6% | 71,932 | +348.5% | 0.07% | +509.1% |
| Q1 2023 | $407,391 | -89.8% | 16,039 | -83.7% | 0.01% | -90.3% |
| Q4 2022 | $3,993,456 | +343.7% | 98,458 | +285.3% | 0.11% | +182.5% |
| Q2 2022 | $900,000 | +1.2% | 25,555 | +32.2% | 0.04% | -4.8% |
| Q1 2022 | $889,000 | +89.6% | 19,330 | +173.2% | 0.04% | +44.8% |
| Q4 2021 | $469,000 | -26.1% | 7,075 | -7.7% | 0.03% | -46.3% |
| Q2 2021 | $635,000 | -52.7% | 7,665 | -62.1% | 0.05% | -56.1% |
| Q1 2021 | $1,342,000 | -21.1% | 20,244 | -24.5% | 0.12% | +21.8% |
| Q4 2019 | $1,701,000 | +1123.7% | 26,812 | +39.2% | 0.10% | +910.0% |
| Q1 2018 | $139,000 | – | 19,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |